Adjuvant chemotherapy schedules for breast cancer according to BMI

Marco Tagliamento, Medical oncologist at Ospedale Policlinico San Martino, shared a post on X:

“Congrats to Francesca Poggio for this publication in ESMO Open.

Efficacy of adjuvant chemotherapy schedules for breast cancer according to BMI within the randomized GIM2 trial.”

Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial

Authors: F Poggio, E Blondeaux, M Tagliamento, M Perachino, S Nardin, B Conte, M Giuliano, G Arpino, M De Laurentiis, A Gravina, G Bisagni, A Rimanti, A Turletti, C Nisticò, E Magnolfi, S Gasparro, A Fabi, O Garrone, M G Alicicco, Y Urracci, P Polett, P Correale, C Molinelli, A Fozza, F Puglisi, G Colantuoni, P Fregatti, L Boni, M Lambertini, and L Del Mastro.

Source: Marco Tagliamento/X